131 related articles for article (PubMed ID: 38376298)
81. Distribution of polymorphisms in the CYP2C9 gene and CYP2C19/CYP2C9 haplotypes among Venezuelan populations.
Flores-Gutiérrez S; Rodríguez-Larralde Á; Vívenes de Lugo M; Castro de Guerra D
Ann Hum Biol; 2017 Mar; 44(2):191-198. PubMed ID: 27230833
[TBL] [Abstract][Full Text] [Related]
82. Impact of
Wang D; Yong L; Zhang Q; Chen H
Pharmacogenomics; 2022 Nov; 23(16):903-911. PubMed ID: 36222113
[No Abstract] [Full Text] [Related]
83. Flow cytometric assay for genotyping cytochrome p450 2C9 and 2C19: comparison with a microelectronic DNA array.
Pickering JW; McMillin GA; Gedge F; Hill HR; Lyon E
Am J Pharmacogenomics; 2004; 4(3):199-207. PubMed ID: 15174901
[TBL] [Abstract][Full Text] [Related]
84. CYP2C19 participates in tolbutamide hydroxylation by human liver microsomes.
Wester MR; Lasker JM; Johnson EF; Raucy JL
Drug Metab Dispos; 2000 Mar; 28(3):354-9. PubMed ID: 10681382
[TBL] [Abstract][Full Text] [Related]
85. Is genetic polymorphism of ER-α, CYP1A1, and CYP1B1 a risk factor for uterine leiomyoma?
El-Shennawy GA; Elbialy AA; Isamil AE; El Behery MM
Arch Gynecol Obstet; 2011 Jun; 283(6):1313-8. PubMed ID: 20559649
[TBL] [Abstract][Full Text] [Related]
86. The Prevalence of CYP2C8, 2C9, 2J2, and soluble epoxide hydrolase polymorphisms in African Americans with hypertension.
Dreisbach AW; Japa S; Sigel A; Parenti MB; Hess AE; Srinouanprachanh SL; Rettie AE; Kim H; Farin FM; Hamm LL; Lertora JJ
Am J Hypertens; 2005 Oct; 18(10):1276-81. PubMed ID: 16202848
[TBL] [Abstract][Full Text] [Related]
87. Distribution of CYP2C8 and CYP2C9 amino acid substitution alleles in South Indian diabetes patients: A genotypic and computational protein phenotype study.
Rao DK; Murthy DK; Shaik NS; Banaganapalli B; Konda K; Rao HP; Ganti E; Ahmed Awan Z; A El-Harouni A; Elango R; Ali Khan I; Shaik NA
Clin Exp Pharmacol Physiol; 2017 Dec; 44(12):1171-1179. PubMed ID: 28686288
[TBL] [Abstract][Full Text] [Related]
88. Differential expression and function of CYP2C isoforms in human intestine and liver.
Läpple F; von Richter O; Fromm MF; Richter T; Thon KP; Wisser H; Griese EU; Eichelbaum M; Kivistö KT
Pharmacogenetics; 2003 Sep; 13(9):565-75. PubMed ID: 12972955
[TBL] [Abstract][Full Text] [Related]
89. Polymorphisms of the CYP1B1 gene and hepatocellular carcinoma risk in a Chinese population.
Liu F; Luo LM; Wei YG; Li B; Wang WT; Wen TF; Yang JY; Xu MQ; Yan LN
Gene; 2015 Jun; 564(1):14-20. PubMed ID: 25796598
[TBL] [Abstract][Full Text] [Related]
90. Tobacco carcinogen-metabolizing genes CYP1A1, GSTM1, and GSTT1 polymorphisms and their interaction with tobacco exposure influence the risk of head and neck cancer in Northeast Indian population.
Choudhury JH; Singh SA; Kundu S; Choudhury B; Talukdar FR; Srivasta S; Laskar RS; Dhar B; Das R; Laskar S; Kumar M; Kapfo W; Mondal R; Ghosh SK
Tumour Biol; 2015 Aug; 36(8):5773-83. PubMed ID: 25724184
[TBL] [Abstract][Full Text] [Related]
91. The effect of polymorphic metabolism enzymes on serum phenytoin level.
Ozkaynakci A; Gulcebi MI; Ergeç D; Ulucan K; Uzan M; Ozkara C; Guney I; Onat FY
Neurol Sci; 2015 Mar; 36(3):397-401. PubMed ID: 25311916
[TBL] [Abstract][Full Text] [Related]
92. Clinically relevant pharmacogenetic markers in Tatars and Balkars.
Abdullaev SP; Mirzaev KB; Burashnikova IS; Shikaleva AA; Kachanova AA; Abdullaev SP; Akmalova KA; Sozaeva ZA; Grishina EA; Sozaeva MS; Rytkin EI; Sychev DA
Mol Biol Rep; 2020 May; 47(5):3377-3387. PubMed ID: 32303955
[TBL] [Abstract][Full Text] [Related]
93. Association of polymorphisms of CYP2C9, CYP2C19, and ABCB1, and activity of P-glycoprotein with response to anti-epileptic drugs.
Taur SR; Kulkarni NB; Gandhe PP; Thelma BK; Ravat SH; Gogtay NJ; Thatte UM
J Postgrad Med; 2014; 60(3):265-9. PubMed ID: 25121365
[TBL] [Abstract][Full Text] [Related]
94. CYP1B1 C4326G polymorphism and susceptibility to cervical cancer in Chinese Han women.
Li Y; Tan SQ; Ma QH; Li L; Huang ZY; Wang Y; Li SW
Tumour Biol; 2013 Dec; 34(6):3561-7. PubMed ID: 23794133
[TBL] [Abstract][Full Text] [Related]
95. The effect of genetic polymorphisms of cytochrome P450 CYP2C9, CYP2C19, and CYP2D6 on drug-resistant epilepsy in Turkish children.
Seven M; Batar B; Unal S; Yesil G; Yuksel A; Guven M
Mol Diagn Ther; 2014 Apr; 18(2):229-36. PubMed ID: 24338437
[TBL] [Abstract][Full Text] [Related]
96. The association between CYP2C9/2C19 polymorphisms and phenytoin maintenance doses in Asian epileptic patients: A systematic review and meta-analysis
.
Liao K; Liu Y; Ai CZ; Yu X; Li W
Int J Clin Pharmacol Ther; 2018 Jul; 56(7):337-346. PubMed ID: 29628024
[TBL] [Abstract][Full Text] [Related]
97. Distribution of CYP2C polymorphisms in an Amerindian population of Brazil.
Vargens DD; Petzl-Erler ML; Suarez-Kurtz G
Basic Clin Pharmacol Toxicol; 2012 Apr; 110(4):396-400. PubMed ID: 21977947
[No Abstract] [Full Text] [Related]
98. CYP1A1 and CYP1B1 genetic polymorphisms and uterine leiomyoma risk in Chinese women.
Ye Y; Cheng X; Luo HB; Liu L; Li YB; Hou YP
J Assist Reprod Genet; 2008 Aug; 25(8):389-94. PubMed ID: 18763031
[TBL] [Abstract][Full Text] [Related]
99. Linkage disequilibrium between the CYP2C19*2,*17 and CYP2C9*1 alleles and impact of VKORC1, CYP2C9, CYP2C19 gene polymorphisms and gene-gene interactions on warfarin therapy.
Khalighi K; Cheng G; Mirabbasi S; Khalighi B; Wu Y; Fan W
J Thromb Thrombolysis; 2017 Jan; 43(1):124-129. PubMed ID: 27743182
[TBL] [Abstract][Full Text] [Related]
100. Effect of eurycomanone on cytochrome P450 isoforms CYP1A2, CYP2A6, CYP2C8, CYP2C9, CYP2C19, CYP2E1 and CYP3A4 in vitro.
Pan Y; Tiong KH; Abd-Rashid BA; Ismail Z; Ismail R; Mak JW; Ong CE
J Nat Med; 2014 Apr; 68(2):402-6. PubMed ID: 23881640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
